CRP and renal cell carcinoma: Platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), and C-reactive protein (CRP), which are inflammatory biomarkers extracted from the peripheral blood, have shown predictive significance in patients with gastric cancer, pancreatic cancer, and renal cell carcinoma (14–16).